In the case reported in this present study (this 58-year-old male patient), both the continuous shrinking of tumor size in the MRI scans and the rapidly decreasing AFP levels during sorafenib treatment indicate that the CR of advanced HCC was induced by sorafenib. The gene discussed is AFP; the disease is hepatocellular carcinoma.